38 related articles for article (PubMed ID: 38427686)
1. Corrigendum to "Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosis" [Vascular Pharmacology 155 (2024) 107368].
Singh B; Cui K; Eisa-Beygi S; Zhu B; Cowan DB; Shi J; Bashur CA; Wang DZ; Liu Z; Bischoff J; Chen H
Vascul Pharmacol; 2024 Jun; 155():107373. PubMed ID: 38658307
[No Abstract] [Full Text] [Related]
2. Endocardial primary cilia and blood flow are required for regulation of EndoMT during endocardial cushion development.
Berg K; Gorham J; Lundt F; Seidman J; Brueckner M
bioRxiv; 2024 May; ():. PubMed ID: 38798559
[TBL] [Abstract][Full Text] [Related]
3. Atheroprone flow enhances the endothelial-to-mesenchymal transition.
Lai B; Li Z; He M; Wang Y; Chen L; Zhang J; Yang Y; Shyy JY
Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1293-H1303. PubMed ID: 30052471
[TBL] [Abstract][Full Text] [Related]
4. CD40 is expressed in the subsets of endothelial cells undergoing partial endothelial-mesenchymal transition in tumor microenvironment.
Takahashi K; Kobayashi M; Katsumata H; Tokizaki S; Anzai T; Ikeda Y; Alcaide DM; Maeda K; Ishihara M; Tahara K; Kubota Y; Itoh F; Park J; Takahashi K; Matsunaga YT; Yoshimatsu Y; Podyma-Inoue KA; Watabe T
Cancer Sci; 2024 Feb; 115(2):490-506. PubMed ID: 38111334
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-155 functions as a negative regulator of RhoA signaling in TGF-β-induced endothelial to mesenchymal transition.
Bijkerk R; de Bruin RG; van Solingen C; Duijs JM; Kobayashi K; van der Veer EP; ten Dijke P; Rabelink TJ; Goumans MJ; van Zonneveld AJ
Microrna; 2012; 1(1):2-10. PubMed ID: 25048084
[TBL] [Abstract][Full Text] [Related]
6. The G-Protein-Coupled Formyl Peptide Receptor 2 Promotes Endothelial-Mesenchymal Transition in Diabetic Retinopathy.
Lou X; Liu S; Shi J; Chen H; Wang Z; Le Y; Chen H; Zhu R; Yu Y
Ophthalmic Res; 2023; 66(1):681-691. PubMed ID: 36805961
[TBL] [Abstract][Full Text] [Related]
7. N-Cadherin Targeted Melanin Nanoparticles Reverse the Endothelial-Mesenchymal Transition in Vascular Endothelial Cells to Potentially Slow the Progression of Atherosclerosis and Cancer.
Liu J; Yu X; Braucht A; Smith S; Wang C
ACS Nano; 2024 Mar; 18(11):8229-8247. PubMed ID: 38427686
[TBL] [Abstract][Full Text] [Related]
8. Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosis.
Singh B; Cui K; Eisa-Beygi S; Zhu B; Cowan DB; Shi J; Wang DZ; Liu Z; Bischoff J; Chen H
Vascul Pharmacol; 2024 Jun; 155():107368. PubMed ID: 38548093
[TBL] [Abstract][Full Text] [Related]
9. Endothelial-to-mesenchymal transition in tumour progression and its potential roles in tumour therapy.
Yin Z; Wang L
Ann Med; 2023 Dec; 55(1):1058-1069. PubMed ID: 36908260
[TBL] [Abstract][Full Text] [Related]
10. Endothelial-to-mesenchymal transition: Pathogenesis and therapeutic targets for chronic pulmonary and vascular diseases.
Lu X; Gong J; Dennery PA; Yao H
Biochem Pharmacol; 2019 Oct; 168():100-107. PubMed ID: 31251941
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
